EVOLUS, INC. Deferred Tax Assets, Tax Deferred Expense, Other
EVOLUS, INC. (EOLS) had Deferred Tax Assets, Tax Deferred Expense, Other of $2.62 million as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2022-03-03
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $2.62M.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $2.62M.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $2.47M.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $2.18M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2021-12-31 | $2.62M 10-K · filed 2022-03-03 |
| 2020-12-31 | $2.62M 10-K · filed 2022-03-03 |
| 2019-12-31 | $2.47M 10-K · filed 2021-03-25 |
| 2018-12-31 | $2.18M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |